Loading clinical trials...
Loading clinical trials...
Single-center, Double-blind, Placebo-controlled, Randomized, Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of AC-076 in Healthy Male Subjects
Conditions
Interventions
AC-076 for s.c. administration
Placebo
Locations
1
United States
Biotrial Inc.
Newark, New Jersey, United States
Start Date
November 29, 2016
Primary Completion Date
April 15, 2017
Completion Date
April 15, 2017
Last Updated
July 2, 2025
NCT06342713
NCT06014515
NCT07219940
NCT07059858
NCT07144176
NCT07114146
Lead Sponsor
Viatris Innovation GmbH
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions